Plain-English translation of NCT05419076 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Lung Cancer research guide →Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing whether stereotactic radiosurgery (SRS)—a highly focused form of radiation therapy—is an effective treatment for people whose small cell lung cancer has spread to the brain. Stereotactic radiosurgery delivers radiation very precisely to brain tumors while minimizing damage to surrounding healthy tissue. The study will enroll about 62 patients to see how well this treatment works and how safe it is.
Small cell lung cancer that spreads to the brain is a serious problem, and doctors want to find better ways to treat it. This trial exists to determine whether this focused radiation treatment could be a valuable option for patients in this situation.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will receive stereotactic radiosurgery—a specialized radiation treatment that targets brain tumors with great precision. The exact schedule and number of visits will depend on how many tumors you have and other factors your doctor discusses with you. You will be monitored over time with imaging scans and follow-up appointments to see how well the treatment is working and to watch for any side effects.
AI-generated summary from trial data · Jun 12, 2026 · Not medical advice
United States